Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
11.06
-0.18 (-1.60%)
Dec 27, 2024, 4:00 PM EST - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $585.81 million as of December 27, 2024. Its market cap has increased by 166.11% in one year.
Market Cap
585.81M
Enterprise Value
321.97M
1-Year Change
166.11%
Ranking
Category
Stock Price
$11.06
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has decreased from $804.46M to $585.81M, a decrease of -27.18%. That is a compound annual growth rate of -5.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2024 | 595.35M | 153.47% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | 926.91M | 15.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 632.03M |
| Pharming Group | 629.37M |
| Entrada Therapeutics | 621.72M |
| Varex Imaging | 604.50M |
| Arbutus Biopharma | 602.58M |
| Autolus Therapeutics | 598.77M |
| Cross Country Healthcare | 591.51M |
| Semler Scientific | 590.81M |